Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Topics:
Medical Oncology
•
Supportive Care
•
Immune-related adverse events
•
Rheumatology
•
Neurology
•
Endocrinology
•
Gynecologic Oncology
•
General Endocrinology
How do you manage suspected hypophysitis/hypopituitarism as an immune-related adverse event?
What lab tests/imaging do you obtain and how do you initially treat?
Related Questions
How do you manage immunotherapy-induced myasthenia gravis?
In SIADH due to malignancy, do you prefer to use free water restriction or salt tablets?
What are magic mouthwash alternatives that you would recommend?
Would you transition from denosumab to anabolic agents in patients who are in urgent need for extensive dental work?
How long can you treat dermatomyositis with IVIG?
What is your approach to differentiating pseudo-Cushing's state from Cushing's syndrome?
For a patient with osteopenia or osteoporosis, how long can intravenous zoledronic acid be maintained if there are not adverse events?
What is your workup for CSF studies when evaluating for possible CNS Lupus?
Do you have a preference of denosumab over zoledronic acid in patients with metastatic breast cancer with osseous involvement with normal renal function?
How do you view the efficacy of estrogen replacement therapy in trans-women with regards to osteoporosis prevention and treatment?